| Siri Lowe; Founder and Chief Executive for the Pemphigus Vulgaris Network |
| Mary Jane Watts, RGN, ENB393; Dermatology Nurse Practitioner; Whipps Cross University Hospital, London |
| Dr Karen Harman, MA, MRCP, DM. Consultant Dermatologist, University Hospitals, Leicester |
| Dr Joanne Chalmers BSc PhD; Research Associate, University of Nottingham |
| Professor Hywel C Williams MSc PhD FRCP, Professor of Dermato-Epidemiology, University of Nottingham |
Date written: July 2005
Date to be updated: July 2007
References
- Burge SM. Hailey-Hailey disease. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Textbook of Dermatology. 7th edition. Oxford: Blackwell Science, 2004: 40.32-40.36.
- Burge SM. Hailey-Hailey disease. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Textbook of Dermatology. 7th edition. Oxford: Blackwell Science, 2004: 41.5-41.13.
- Harman KE, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype. Br J Dermatol 2000;143:343-348.
- Becker BA, Gaspari AA. Pemphigus vulgaris and vegetans. Dermatol Clin 1993;11(3):429-52.
- Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 1982;306(20):1189-96.
- Amagai M, Hashimoto T, Shimizu N, Nishikawa T. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 1994;94(1):59- 67.
- Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol 1996;132(2):203-12.
- Ratnam KV, Phay KL, Tan CK. Pemphigus therapy with oral prednisolone regimens. Int J Dermatol 1990;29:363-7.
- Carson PJ, Hameed A, Ahmed AR. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol 1996;34(4):645-52.
- Tur E, Brenner S. Contributing exogenous factors in pemphigus. Int J Dermatol 1997;36:999-93.
- Brenner S, Wolf R. Possible nutritional factors in induced pemphigus. Dermatology 1994;189:337-9.
- Mutasim DF, Pelc NJ, Anhalt GJ. Drug-induced pemphigus. Dermatologic Clinics 1993;11(3):463-71.
- Herbst A, Bystryn J-C. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol 2000;42:422-7.
- Kyriakis KP, Tosca AD. Epidemiologic observations on the natural course of pemphigus vulgaris. Int J Dermatol 1998;37:215-219.
- Harman KE, Gratian MJ, Seed PT, Bhogal BS, Challacombe SJ, Black MM. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Clin Exp Dermatol 1999;25:236-240.
- Harman KE, Albert S, Black MM. Guidelines for the management of pemphigus vulgaris. Br J Dermatol 2003;149:926-37.
- Society BaT, Society NO, Physicians RCo. Glucocorticoid-induced osteoporosis: guidelines for prevention and treatment. London: RCP, 2002.
Anecdotal evidence from the pemphigus vulgaris network has been incorporated into this website.
Acknowledgments
We are grateful for the input of the International Pemphigus Foundation via their website: http://www.pemphigus.org
|